Wang et al [96] documented that MBP immunoreactivity is significantly lower in the white matter of subjects with Alzheimer disease than in subjects without cognitive impairment, suggesting that a deficiency of MBP expression in white matter may contribute to an age-associated decline in cognition. This evidence concerns the gene MBP and early-onset autosomal dominant Alzheimer disease.